Impact of remifentanil introduction on practice patterns in general anesthesia

Kanji Uchida, Hideo Yasunaga, Hiroaki Miyata, Masahiko Sumitani, Hiromasa Horiguchi, Ken Kuwajima, Shinya Matsuda, Yoshitsugu Yamada

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose: The introduction of new medicine can change clinical practice patterns and may affect patient outcomes. In the present study, we investigated whether introduction of remifentanil in Japan affected the practice patterns of anesthesia. Methods: Using the Japanese Diagnosis Procedure Combination database, we extracted records of 423,491 patients who underwent surgery with general anesthesia in 243 hospitals before (2006) and after (2007) the introduction of remifentanil, and identified anesthetic agents used for each patient. A hierarchical mixed-effects logistic regression analysis was performed to analyze the factors that affected selection of remifentanil. Further, we compared postoperative length of stay (LOS), in-hospital mortality, and total costs between 2006 and 2007. Results: In 2007, remifentanil was used for up to 41.4% of all general anesthesia, accompanied by a reduction in nitrous oxide use and an increase in total intravenous anesthesia. Female gender, increasing age, and preoperative comorbidities including diabetes mellitus, hypertension, liver cirrhosis, and chronic renal failure were positively associated with the use of remifentanil, whereas accompanying cardiac disease and co-application of epidural anesthesia were negatively associated. In 2007, a similar in-hospital death rate, similar or decreased total costs, slightly reduced duration of anesthesia, and substantially reduced postoperative LOS were seen compared to those in 2006. Conclusions: Our data revealed rapid changes in practice patterns in anesthesia after the introduction of remifentanil in Japan. Remifentanil was used more often in patients with comorbidities and without epidural anesthesia, and its introduction did not affect increase in total medical costs.

Original languageEnglish
Pages (from-to)864-871
Number of pages8
JournalJournal of Anesthesia
Volume25
Issue number6
DOIs
Publication statusPublished - 2011 Dec
Externally publishedYes

Fingerprint

General Anesthesia
Anesthesia
Epidural Anesthesia
Costs and Cost Analysis
Comorbidity
Length of Stay
Japan
Physicians' Practice Patterns
Intravenous Anesthesia
Nitrous Oxide
Hospital Mortality
remifentanil
Liver Cirrhosis
Statistical Factor Analysis
Chronic Kidney Failure
Anesthetics
Heart Diseases
Diabetes Mellitus
Logistic Models
Regression Analysis

Keywords

  • Anesthetic practice
  • In-patient medical cost
  • Postoperative outcome
  • Remifentanil

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Uchida, K., Yasunaga, H., Miyata, H., Sumitani, M., Horiguchi, H., Kuwajima, K., ... Yamada, Y. (2011). Impact of remifentanil introduction on practice patterns in general anesthesia. Journal of Anesthesia, 25(6), 864-871. https://doi.org/10.1007/s00540-011-1221-5

Impact of remifentanil introduction on practice patterns in general anesthesia. / Uchida, Kanji; Yasunaga, Hideo; Miyata, Hiroaki; Sumitani, Masahiko; Horiguchi, Hiromasa; Kuwajima, Ken; Matsuda, Shinya; Yamada, Yoshitsugu.

In: Journal of Anesthesia, Vol. 25, No. 6, 12.2011, p. 864-871.

Research output: Contribution to journalArticle

Uchida, K, Yasunaga, H, Miyata, H, Sumitani, M, Horiguchi, H, Kuwajima, K, Matsuda, S & Yamada, Y 2011, 'Impact of remifentanil introduction on practice patterns in general anesthesia', Journal of Anesthesia, vol. 25, no. 6, pp. 864-871. https://doi.org/10.1007/s00540-011-1221-5
Uchida, Kanji ; Yasunaga, Hideo ; Miyata, Hiroaki ; Sumitani, Masahiko ; Horiguchi, Hiromasa ; Kuwajima, Ken ; Matsuda, Shinya ; Yamada, Yoshitsugu. / Impact of remifentanil introduction on practice patterns in general anesthesia. In: Journal of Anesthesia. 2011 ; Vol. 25, No. 6. pp. 864-871.
@article{cd6206f8c6a44eb9aa1904b57066057c,
title = "Impact of remifentanil introduction on practice patterns in general anesthesia",
abstract = "Purpose: The introduction of new medicine can change clinical practice patterns and may affect patient outcomes. In the present study, we investigated whether introduction of remifentanil in Japan affected the practice patterns of anesthesia. Methods: Using the Japanese Diagnosis Procedure Combination database, we extracted records of 423,491 patients who underwent surgery with general anesthesia in 243 hospitals before (2006) and after (2007) the introduction of remifentanil, and identified anesthetic agents used for each patient. A hierarchical mixed-effects logistic regression analysis was performed to analyze the factors that affected selection of remifentanil. Further, we compared postoperative length of stay (LOS), in-hospital mortality, and total costs between 2006 and 2007. Results: In 2007, remifentanil was used for up to 41.4{\%} of all general anesthesia, accompanied by a reduction in nitrous oxide use and an increase in total intravenous anesthesia. Female gender, increasing age, and preoperative comorbidities including diabetes mellitus, hypertension, liver cirrhosis, and chronic renal failure were positively associated with the use of remifentanil, whereas accompanying cardiac disease and co-application of epidural anesthesia were negatively associated. In 2007, a similar in-hospital death rate, similar or decreased total costs, slightly reduced duration of anesthesia, and substantially reduced postoperative LOS were seen compared to those in 2006. Conclusions: Our data revealed rapid changes in practice patterns in anesthesia after the introduction of remifentanil in Japan. Remifentanil was used more often in patients with comorbidities and without epidural anesthesia, and its introduction did not affect increase in total medical costs.",
keywords = "Anesthetic practice, In-patient medical cost, Postoperative outcome, Remifentanil",
author = "Kanji Uchida and Hideo Yasunaga and Hiroaki Miyata and Masahiko Sumitani and Hiromasa Horiguchi and Ken Kuwajima and Shinya Matsuda and Yoshitsugu Yamada",
year = "2011",
month = "12",
doi = "10.1007/s00540-011-1221-5",
language = "English",
volume = "25",
pages = "864--871",
journal = "Journal of Anesthesia",
issn = "0913-8668",
publisher = "Springer Japan",
number = "6",

}

TY - JOUR

T1 - Impact of remifentanil introduction on practice patterns in general anesthesia

AU - Uchida, Kanji

AU - Yasunaga, Hideo

AU - Miyata, Hiroaki

AU - Sumitani, Masahiko

AU - Horiguchi, Hiromasa

AU - Kuwajima, Ken

AU - Matsuda, Shinya

AU - Yamada, Yoshitsugu

PY - 2011/12

Y1 - 2011/12

N2 - Purpose: The introduction of new medicine can change clinical practice patterns and may affect patient outcomes. In the present study, we investigated whether introduction of remifentanil in Japan affected the practice patterns of anesthesia. Methods: Using the Japanese Diagnosis Procedure Combination database, we extracted records of 423,491 patients who underwent surgery with general anesthesia in 243 hospitals before (2006) and after (2007) the introduction of remifentanil, and identified anesthetic agents used for each patient. A hierarchical mixed-effects logistic regression analysis was performed to analyze the factors that affected selection of remifentanil. Further, we compared postoperative length of stay (LOS), in-hospital mortality, and total costs between 2006 and 2007. Results: In 2007, remifentanil was used for up to 41.4% of all general anesthesia, accompanied by a reduction in nitrous oxide use and an increase in total intravenous anesthesia. Female gender, increasing age, and preoperative comorbidities including diabetes mellitus, hypertension, liver cirrhosis, and chronic renal failure were positively associated with the use of remifentanil, whereas accompanying cardiac disease and co-application of epidural anesthesia were negatively associated. In 2007, a similar in-hospital death rate, similar or decreased total costs, slightly reduced duration of anesthesia, and substantially reduced postoperative LOS were seen compared to those in 2006. Conclusions: Our data revealed rapid changes in practice patterns in anesthesia after the introduction of remifentanil in Japan. Remifentanil was used more often in patients with comorbidities and without epidural anesthesia, and its introduction did not affect increase in total medical costs.

AB - Purpose: The introduction of new medicine can change clinical practice patterns and may affect patient outcomes. In the present study, we investigated whether introduction of remifentanil in Japan affected the practice patterns of anesthesia. Methods: Using the Japanese Diagnosis Procedure Combination database, we extracted records of 423,491 patients who underwent surgery with general anesthesia in 243 hospitals before (2006) and after (2007) the introduction of remifentanil, and identified anesthetic agents used for each patient. A hierarchical mixed-effects logistic regression analysis was performed to analyze the factors that affected selection of remifentanil. Further, we compared postoperative length of stay (LOS), in-hospital mortality, and total costs between 2006 and 2007. Results: In 2007, remifentanil was used for up to 41.4% of all general anesthesia, accompanied by a reduction in nitrous oxide use and an increase in total intravenous anesthesia. Female gender, increasing age, and preoperative comorbidities including diabetes mellitus, hypertension, liver cirrhosis, and chronic renal failure were positively associated with the use of remifentanil, whereas accompanying cardiac disease and co-application of epidural anesthesia were negatively associated. In 2007, a similar in-hospital death rate, similar or decreased total costs, slightly reduced duration of anesthesia, and substantially reduced postoperative LOS were seen compared to those in 2006. Conclusions: Our data revealed rapid changes in practice patterns in anesthesia after the introduction of remifentanil in Japan. Remifentanil was used more often in patients with comorbidities and without epidural anesthesia, and its introduction did not affect increase in total medical costs.

KW - Anesthetic practice

KW - In-patient medical cost

KW - Postoperative outcome

KW - Remifentanil

UR - http://www.scopus.com/inward/record.url?scp=84355163009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84355163009&partnerID=8YFLogxK

U2 - 10.1007/s00540-011-1221-5

DO - 10.1007/s00540-011-1221-5

M3 - Article

VL - 25

SP - 864

EP - 871

JO - Journal of Anesthesia

JF - Journal of Anesthesia

SN - 0913-8668

IS - 6

ER -